NeuroMetrix, Inc. (NURO) financial statements (2021 and earlier)

Company profile

Business Address 1000 WINTER STREET
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments53744129
Cash and cash equivalents53744129
Receivables0011111
Inventory, net of allowances, customer advances and progress billings1131111
Inventory1131111
Deferred costs   21  
Other undisclosed current assets0111111
Total current assets:7512981511
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment0000110
Other undisclosed noncurrent assets0000000
Total noncurrent assets:1100110
TOTAL ASSETS:87121081611
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1234333
Accounts payable0111111
Accrued liabilities1122211
Employee-related liabilities   1011
Taxes payable      0
Debt 1     
Deferred revenue and credits  00
Other undisclosed current liabilities11311 (0)
Total current liabilities:2365333
Noncurrent Liabilities
Long-term debt and lease obligation01     
Operating lease, liability01
Liabilities, other than long-term debt      0
Deferred revenue and credits   0
Other undisclosed noncurrent liabilities(0)   005
Total noncurrent liabilities:01  005
Total liabilities:3465338
Stockholders' equity
Stockholders' equity attributable to parent, including:53655133
Common stock0000000
Additional paid in capital202197197196183176158
Accumulated deficit(197)(195)(191)(191)(178)(164)(154)
Other undisclosed stockholders' equity attributable to parent0000000
Total stockholders' equity:53655133
TOTAL LIABILITIES AND EQUITY:87121081611

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues7916171276
Other operating income  12    
Cost of revenue(2)(7)(9)(10)(7)(4)(3)
Cost of goods and services sold (3)     
Gross profit:5277533
Operating expenses(7)(14)(20)(20)(20)(17)(12)
Operating loss:(2)(12)(12)(13)(15)(13)(9)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
08    (0)
Loss before gain (loss) on sale of properties:(2)(4)(12)(13)(15)(13)(9)
Other undisclosed net income  12    
Net income (loss):(2)(4)0(13)(15)(13)(9)
Other undisclosed net income attributable to parent   0041
Net income (loss) attributable to parent:(2)(4)0(13)(15)(9)(8)
Preferred stock dividends and other adjustments   (7)(20)  
Other undisclosed net loss available to common stockholders, basic     (12)(3)
Net income (loss) available to common stockholders, diluted:(2)(4)0(20)(35)(21)(11)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(2)(4)0(13)(15)(13)(9)
Comprehensive income (loss), net of tax, attributable to parent:(2)(4)0(13)(15)(13)(9)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: